BRIEF published on 10/24/2024 at 17:50, 1 year 1 month ago Cegedim: Steady Revenue Growth in Q3 2024 Driven by Key Sectors Revenue Growth Cloud Services Q3 2024 Data & Marketing BPO Performance
REGULATED PRESS RELEASE published on 10/24/2024 at 17:45, 1 year 1 month ago Cegedim: Revenue growth continued in the third quarter of 2024 Cegedim's Q3 2024 revenue grows 5.7%, led by Marketing, BPO, HR, and cloud businesses. Total revenue for 9M2024 increases by 5.9% to €475.8 million. Quarterly financial breakdown provided Financial Information Revenue Growth Q3 2024 Cegedim Business Trends
BRIEF published on 10/10/2024 at 08:35, 1 year 1 month ago Strategic partnership between Cegedim and PHAST to improve the traceability of medical devices Interoperability Strategic Partnership Digital Health DMI Traceability Hospital Management
BRIEF published on 10/03/2024 at 08:35, 1 year 2 months ago Strategic partnership between Claude Bernard and Medipim Strategic Partnership Claude Bernard Medipim Health Products Single API
BRIEF published on 09/18/2024 at 08:35, 1 year 2 months ago Cegedim Assurances obtains a new certification: ISO 22301 Certification Résilience Business Continuity ISO 22301 Cegedim Insurance
BRIEF published on 07/31/2024 at 17:50, 1 year 4 months ago Cegedim Secures €230 Million Financing Arrangement Credit Facility Syndicated Loan Debt Refinancing Financing Arrangement Cegedim
PRESS RELEASE published on 07/31/2024 at 17:45, 1 year 4 months ago Cegedim: New €230 million financing arrangement Cegedim secures new €230 million financing arrangement, comprising a €180 million refinancing loan and a €50 million revolving credit facility, enhancing liquidity and extending debt maturity Revolving Credit Facility Financing Arrangement Cegedim €230 Million Refinancing Loan
BRIEF published on 05/14/2024 at 08:35, 1 year 6 months ago Claude Bernard launches a new web component portal for healthcare publishers Interoperability Software Integration Web Portal Database Health Edition
PRESS RELEASE published on 03/27/2024 at 17:45, 1 year 8 months ago Cegedim Full year 2023 results: Revenue and recurring operating income both up
PRESS RELEASE published on 07/04/2023 at 18:40, 2 years 5 months ago Cegedim: Half-year liquidity contract statement
Published on 12/05/2025 at 02:35, 2 hours 49 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 24 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 19 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 24 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 33 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 9 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 24 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 39 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 40 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 23 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
